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Abstract To define domains of the human MxA GTPase
involved in GTP hydrolysis and antiviral activity, we used two
monoclonal antibodies (mAb) directed against different regions
of the molecule. mAb 2C12 recognizes an epitope in the central
interactive region of MxA, whereas mAb M143 is directed
against the N-terminal G domain. mAb 2C12 greatly stimulated
MxA GTPase activity, suggesting that antibody-mediated
crosslinking enhances GTP hydrolysis. In contrast, monovalent
Fab fragments of 2C12 abolished GTPase activity, most likely
by blocking intramolecular interactions required for GTPase
activation. Interestingly, intact IgG molecules and Fab frag-
ments of 2C12 both prevented association of MxA with viral
nucleocapsids and neutralized MxA antiviral activity in vivo.
mAb M143 had no effect on MxA function, indicating that this
antibody binds outside functional regions. These data demon-
strate that the central region recognized by 2C12 is critical for
regulation of GTPase activity and viral target recognition.
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1. Introduction
Mx proteins belong to the superfamily of dynamin-like
GTPases. These di¡er from small GTPases and heterotrimeric
G proteins in features such as their large size (70^100 kDa), a
relatively low a⁄nity for GTP, and a high intrinsic rate of
GTP hydrolysis [1,2]. They contain a highly conserved tripar-
tite GTP binding motif within the N-terminal G domain. The
less conserved C-terminal part serves di¡erent functions like
homooligomerization and association with partner molecules
[3]. Homooligomerization seems to be essential for biological
activity. Self-assembly of dynamin, for example, stimulates its
GTPase activity [4] and is crucial for dynamin-mediated en-
docytotic processes [5^7]. Mx proteins also form homooligom-
ers of high molecular weight [8,9]. Two distinct regions of
human MxA, a central interactive region (amino acids 372^
540) and a C-terminal leucine zipper motif (amino acids 564^
662), are responsible for intra- and intermolecular interac-
tions. This has been shown in previous experiments using a
cotranslocation assay [10] or the yeast two-hybrid system [11].
In addition, biochemical studies with protease-digested MxA
demonstrated that association of the C-terminal leucine zipper
motif with the N-terminal half of the protein is required for
GTP hydrolysis, indicating that the C-terminal region pos-
sesses GTPase-activating function [12]. A functional GTP
binding motif was shown to be necessary for the antiviral
activity of MxA [10,13]. We recently demonstrated a physical
association of MxA with viral nucleocapsids of Thogoto virus
(THOV) [14], an orthomyxovirus that is extremely sensitive to
the antiviral e¡ect of MxA [15]. Interaction of MxA with viral
target structures was dependent on the presence of GTPQS, a
non-hydrolyzable GTP analogue, indicating that the GTP-
bound form of MxA has the antivirally active conformation
[16]. Moreover, microinjection of nucleocapsids of THOV
into MxA-expressing cells showed that MxA blocks the trans-
port of these viral structures into the nucleus, the site of
THOV replication [17].
Here, we investigated the involvement of de¢ned regions of
MxA in GTP hydrolysis and antiviral activity by utilizing two
monoclonal antibodies (mAb). mAb M143 binds to a N-ter-
minal epitope, whereas mAb 2C12 recognizes a central epit-
ope of MxA. We show that preincubation of MxA with mAb
2C12 has a dramatic e¡ect on the intrinsic GTPase activity,
con¢rming that the central interactive region is involved in
activation of GTP hydrolysis. The same antibody prevented
cosedimentation of MxA with viral nucleocapsids and neutral-
ized its antiviral activity in vivo. In contrast, mAb M143 had
no e¡ect on MxA function. These data indicate that the cen-
tral 2C12 binding site of MxA is involved in regulation of
both GTPase activity and viral target recognition within the
infected cell.
2. Materials and methods
2.1. Antibodies
mAb M143 was produced in hybridoma cells from mice immunized
with His-tagged MxA protein puri¢ed from Escherichia coli [13]. mAb
2C12 was raised against the murine Mx1 protein but cross-reacts with
the human MxA protein [18,19]. mAb 1622 directed against the SV40
large T antigen was used as a control [20]. The monoclonal antibodies
were puri¢ed from hybridoma cell culture supernatants by protein A-
Sepharose chromatography. Fab fragments were prepared by diges-
tion with immobilized papain (Pierce) and subsequent gel ¢ltration
using a Superdex-200-HR 16/60 column (Pharmacia). All antibody
preparations were concentrated using Centricon 30 (Amicon) to a
concentration of 2 mg/ml in 10 mM Tris^HCl, pH 7.5, 120 mM KCl.
2.2. Immunoprecipitation
MxA-expressing Swiss 3T3 cells (clone 4.5.15) [21] were metabol-
ically labeled for 8 h by incubation with 50 WCi/ml [35S]methionine in
medium lacking methionine. Lysates were prepared in 50 mM Tris,
pH 7.5, 0.1% Nonidet P-40, 5 mM MgCl2, and 0.5 mM DTT. The
lysates were mixed with 5 Wg of puri¢ed intact IgGs and protein
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A-Sepharose and incubated for 2 h at 4‡C. Subsequently, the Sephar-
ose beads were collected, and the bound 35S-labeled proteins were
analyzed by SDS-polyacrylamide gel electrophoresis and autoradiog-
raphy.
2.3. Isolation of His-tagged MxA and GTPase assay
Histidine-tagged MxA was produced in E. coli and isolated using
Ni2-chelate chromatography as described [13]. MxA was further pu-
ri¢ed by Mono Q ion exchange chromatography in 20 mM Tris^HCl,
pH 8.0, 5 mM MgCl2, 10% glycerol, 300 mM NaCl [14].
GTPase activity was determined as described [9]. Brie£y, 1 Wg of
puri¢ed MxA was incubated for 20 min at 37‡C in 50 mM Tris^HCl,
pH 8.0, 5 mM MgCl2, 100 mM KCl, 10% glycerol, 0.1 mM dithio-
threitol, 100 nM AMP-PNP, 13 nM [K-32P]GTP (3000 Ci/mmol), and
1 mM GTP. The reaction was terminated by the addition of SDS and
EDTA to ¢nal concentrations of 0.5% and 2 mM, respectively. Nu-
cleotides were separated by thin layer chromatography on polyethyl-
eneimine^cellulose plates in 1 M LiCl and 1 M acetic acid. The signals
were quanti¢ed by Phosphoimager (Fujix BAS1000, Fuji). To analyze
the e¡ect of the antibodies, 1 Wg of puri¢ed MxA was preincubated
with 1 Wg of IgG molecules or Fab fragments for 20 min at 25‡C prior
to the GTPase assay.
2.4. Cosedimentation of MxA with viral RNPs in glycerol gradient
centrifugation
Cosedimentation assays were performed as previously described
[14]. Brie£y, lysates of MxA-expressing cells (clone 4.5.15) were mixed
with lysates of non-infected cells or THOV-infected cells in the pres-
ence of 200 WM GTPQS. The mixture was subjected to glycerol gra-
dient centrifugation and the resulting fractions were analyzed by
Western blotting using antibodies directed against MxA and THOV
nucleoprotein. To assess the in£uence of mAbs, MxA cell lysates were
treated with 6 Wg of mAbs or Fab fragments before incubation with
lysates of THOV-infected cells.
2.5. Microinjection of antibodies and virus infection
Swiss mouse 3T3 cells constitutively expressing MxA (clone 4.5.15)
were seeded onto glass coverslips and antibodies (1 Wg/Wl) were micro-
injected into the cytoplasm of the cells as described [17]. Five hours
later, the cells were infected with 50 plaque forming units of THOV
per cell. After 16 h, the cells were ¢xed and analyzed by double
immuno£uorescence. Viral proteins were detected using a guinea pig
anti-THOV antiserum and a corresponding TRITC-conjugated sec-
ondary antibody. DTAF-conjugated goat anti-mouse antibodies
were used to detect the microinjected mouse IgGs.
3. Results
Two mAbs were used to characterize regions of MxA in-
volved in GTP hydrolysis and antiviral activity. The ¢rst
mAb, M143, was generated by immunizing mice with re-
combinant human MxA protein. The second mAb, 2C12, is
directed against murine Mx1 protein and cross-reacts with
human MxA [18,19]. Both antibodies recognized full-length
MxA and immunoprecipitated the native protein from lysates
of MxA-expressing cells (Fig. 1A). For further characteriza-
tion, MxA fragments were fused to GST and expressed in E.
coli [14]. mAb M143 recognizes an epitope in the N-terminal
G domain of MxA (amino acids 1^363), whereas mAb 2C12
binds to a central region (amino acids 372^540) (data not
shown, summarized in Fig. 1B). Using shorter fragments of
rat Mx3, Johannes et al. determined the 2C12 binding site to
be located between amino acids 430 and 469 of rat Mx3 [22].
This region is well conserved between Mx proteins and cor-
responds to amino acids 432^471 of human MxA (Fig. 1C,
upper three lines).
3.1. Antibody 2C12 a¡ects GTP hydrolysis of MxA
MxA has a tripartite GTP binding motif in its N-terminus
(Fig. 1B). The importance of this motif for GTP binding and
hydrolysis has been documented by mutational analysis
[10,13]. Therefore, it was conceivable that binding of M143
to the N-terminal G domain of MxA would a¡ect GTP hy-
drolysis. We performed GTPase assays in the presence of
mAbs M143 or 2C12 (Fig. 2). Preincubation of recombinant
MxA with IgGs or Fab fragments of M143 had no e¡ect on
GTPase activity (Fig. 2; M143) suggesting that this antibody
binds outside the critical region involved in GTP binding and
hydrolysis. In contrast, preincubation of MxA with monova-
lent Fab fragments of antibody 2C12 reduced GTPase activity
approximately ¢ve-fold (Fig. 2; 2C12 (Fab)). Surprisingly,
preincubation of MxA with whole IgG molecules of 2C12
had a stimulating e¡ect on GTP hydrolysis (Fig. 2A; 2C12
(IgG)). Quanti¢cation of GDP production in these assays re-
vealed a 2.6-fold increase in GTP hydrolysis as compared to
the M143-treated or untreated controls (Fig. 2B). This unex-
pected result suggests that antibody-mediated crosslinking of
MxA stimulates GTP hydrolysis.
Fig. 1. Regions of MxA recognized by monoclonal antibodies 2C12
and M143. A: Immunoprecipitation of MxA by mAbs 2C12 and
M143. 35S-labeled extracts of MxA-expressing cells were incubated
with antibodies 2C12 and M143, or with an irrelevant control anti-
body. The complex was precipitated using protein A-Sepharose
beads. The labeled proteins were analyzed by SDS-polyacrylamide
gel electrophoresis and autoradiography. B: Domain structure of
human MxA showing the N-terminal tripartite GTP binding region
(black boxes), the central interactive region (striped box), and the
C-terminal leucine zipper motif (LZ; gray box). The regions recog-
nized by monoclonal antibodies M143 and 2C12 are indicated by
black bars. C: Sequence alignment of the 2C12 binding region ac-
cording to Johannes et al. [22]. The sequences of human MxA [29],
rat Mx3 [30], mouse Mx1 [31], human dynamin-1 [32], and yeast
Vps1 [33] are shown in the alignment. Identity is indicated by black
boxes, and similarity by gray boxes.
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3.2. Binding of MxA to viral nucleocapsids is prevented by
mAb 2C12
We recently described an association of MxA with viral
nucleocapsids [14]. When lysates of MxA-expressing cells
were mixed with lysates of THOV-infected cells, a fraction
of MxA cosedimented with the viral nucleocapsids into the
glycerol gradient. In contrast, MxA remained at the top of the
gradient in the absence of viral nucleocapsids (Fig. 3A,B).
This interaction could be prevented by preincubation of
MxA with mAb 2C12 (Fig. 3C) [14]. Because intact IgG
and Fab fragments of mAb 2C12 had opposite e¡ects on
GTP hydrolysis, we compared the ability of these two anti-
body preparations to prevent binding of MxA to viral nucle-
ocapsids. Interestingly, Fab fragments had the same e¡ect as
intact IgG molecules and abolished cosedimentation of MxA
with the viral nucleocapsids (Fig. 3D). Pretreatment of MxA
with IgG or Fab fragments of M143 did not interfere with
nucleocapsid recognition. Thus, MxA continued to cosedi-
ment with the viral nucleocapsids to fractions of higher den-
sity (Fig. 3E,F). The di¡erent behavior of the two mAbs in
the MxA cosedimentation assay suggests that the central in-
teractive region of MxA is critically involved in nucleocapsid
recognition and that binding of M143 to the N-terminal part
does not a¡ect this activity.
3.3. 2C12 but not M143 abolishes the antiviral activity of MxA
We next investigated the e¡ect of intact antibodies and Fab
fragments on the antiviral activity of MxA in living cells. Cells
constitutively expressing MxA were microinjected with the
di¡erent antibody preparations and subsequently infected
with THOV. Viral proteins and microinjected antibodies
were visualized by double immuno£uorescence, using appro-
priate antisera. Intact IgGs of 2C12 neutralized the antiviral
activity of human MxA (Fig. 4a,b), thus con¢rming previous
results [17]. Cells microinjected with Fab fragments of 2C12
also became permissive for THOV infection (Fig. 4e,f), indi-
cating that binding of the 2C12 fragments to MxA was su⁄-
cient to neutralize the antiviral e¡ect of MxA. Likewise, 2C12
also neutralized the antiviral activity of MxA against in£uenza
A virus and vesicular stomatitis virus (data not shown). These
results demonstrated that the 2C12 binding site is crucial for
the antiviral activity of MxA against all three viruses. In con-
trast, MxA-expressing cells microinjected with whole IgGs or
Fab fragments of M143 did not produce viral proteins, indi-
cating that the antiviral activity of MxA was una¡ected (Fig.
4c,d,g,h).
4. Discussion
We used two mAbs to characterize domains of human MxA
that are important for GTP hydrolysis, association with viral
nucleocapsids and antiviral activity. mAb M143 had no e¡ect
in all three test systems. The antibody recognizes an epitope
that is located within the N-terminal half of MxA (amino
acids 1^363). This domain contains the sequence elements
necessary for GTP binding [23,24]. Because M143 did not
show any e¡ect on MxA function, the antibody most likely
binds to an epitope that is not involved in GTP binding and
hydrolysis.
In contrast, mAb 2C12 had a strong e¡ect on GTP hydrol-
ysis, abolished the ability of MxA to associate with viral tar-
get structures, and neutralized its antiviral activity, indicating
that the central interactive region recognized by 2C12 is cru-
cial for MxA function. This region (amino acids 372^540; Fig.
1B) is involved in intra- and intermolecular interactions
[10,14]. It has been proposed that the C-terminus containing
the leucine zipper motif (amino acids 564^662) interacts with
the central interactive region [11]. In fact, biochemical studies
have shown that the last 98 C-terminal amino acids need to
interact with the N-terminal core of the molecule to activate
GTP hydrolysis [12]. Most likely, this intramolecular interac-
tion of the C-terminus is blocked by binding of 2C12 Fab
fragments to the central interactive region, leading to inhib-
ition of GTP hydrolysis.
A GTPase-activating e¡ect has also been described for the
so-called GTPase e¡ector domain (GED) of dynamin. This
region (amino acids 618^752 of human dynamin-1) is able
to stimulate GTPase activity of the N-terminal G domain of
dynamin [6,25]. A yeast two-hybrid analysis suggests a direct
interaction of GED with the so-called middle domain (amino
acids 320^498) of dynamin [26] which re£ects the results de-
scribed for MxA [11]. Therefore, we compared the amino acid
sequences of the middle domain of human dynamin-1 with the
sequence of the 2C12 recognition site of various Mx proteins.
Intriguingly, we found a cluster of mostly hydrophobic and
basic amino acids that are highly conserved among these
members of the dynamin-like GTPase superfamily, including
a putative central interactive region of yeast Vps-1 (Fig. 1C).
We assume that this region comprises the motif that interacts
with the C-terminal leucine zipper motif of MxA (or the GED
of dynamin) and is necessary for the GTPase-activating e¡ect
on the N-terminal G domain.
Why does the intact 2C12 antibody not have the same in-
hibitory e¡ect on GTP hydrolysis as its Fab fragments? The
simplest explanation is that intermolecular crosslinking of
MxA to higher oligomeric structures by bivalent IgGs stimu-
lates GTP hydrolysis. Aggregation of Mx oligomers could
result in an interaction of C-terminal leucine zipper motifs
with N-terminal G domains of neighboring molecules and
Fig. 2. E¡ect of monoclonal antibodies 2C12 and M143 on MxA
GTPase activity. Recombinant His-MxA puri¢ed from E. coli (1 Wg/
assay) was incubated with radiolabeled GTP for 20 min at 37‡C.
MxA was preincubated with whole IgG molecules or Fab fragments
(1 Wg/assay) of mAbs M143 or 2C12, as indicated in Section 2. A:
Autoradiograph of the reaction products after thin layer chromatog-
raphy. B: Quantitative analysis of the GTPase activity was normal-
ized to the activity of MxA alone.
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thereby enhances GTP hydrolysis. Interestingly, incubation of
MxA with whole IgGs of M143 had no stimulating e¡ect on
GTP hydrolysis suggesting that the orientation of the cross-
linked Mx molecules is critical. Crosslinking of MxA mole-
cules via their N-termini by M143 most likely does not pro-
mote interactions between C-terminus and G domain.
In the case of dynamin, crosslinking by antibodies or by
arti¢cial templates such as microtubules also stimulates
GTPase activity [4,27]. It has been proposed that activation
of GTP hydrolysis in oligomeric structures is important for
dynamin function, namely membrane ¢ssion [5^7,28]. These
and the present data suggest that stimulation of GTP hydrol-
ysis by the formation of high-ordered structures is in general a
critical event in the function of dynamin-like GTPases.
Changes in the GTPase activity of Mx proteins may have a
direct e¡ect on their antiviral function. Mutational modi¢ca-
tions within the G domain of MxA that abrogated GTP bind-
ing and hydrolysis abolished antiviral activity [10,13]. There-
fore, we expected opposite e¡ects of intact IgGs and Fab
fragments of 2C12 on viral target recognition and inhibition
of virus replication. Surprisingly, both 2C12 preparations
blocked these activities, indicating that the in£uence of 2C12
on GTP hydrolysis and on antiviral activity is not directly
correlated. Both 2C12 preparations inhibited the association
of MxA with viral nucleocapsids suggesting either that the
central interactive region is directly involved in this recogni-
tion event or, alternatively, that binding of 2C12 prevents the
formation of an additional interactive domain necessary for
nucleocapsid recognition. Coprecipitation experiments with
MxA fragments showed that a complex structure is necessary
for proper interaction of MxA with viral nucleocapsids [16].
The entire C-terminal half of MxA (amino acids 363^662)
with the central interactive region and the C-terminal leucine
zipper motif is required, whereas deletions of one or the other
of these regions abolishes binding to nucleocapsids. Micro-
injection of 2C12 in MxA-expressing cells most likely blocks
viral target recognition by a similar mechanism. A mutational
analysis of the central interactive region of MxA is under way
to identify the critical residues involved in these interactive
events.
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Fig. 4. mAb 2C12, but not M143, neutralizes the antiviral e¡ect of
MxA. MxA-expressing cells were microinjected with either intact
IgGs of 2C12 (a,b) and M143 (c,d) or with Fab fragments of 2C12
(e,f) and M134 (g,h). The cells were infected with THOV, ¢xed 16 h
later and analyzed by double immuno£uorescence. Viral protein
synthesis was detected using an anti-THOV antiserum (b,d,f,h) and
the microinjected antibodies were visualized with a £uorescein-con-
jugated goat anti-mouse IgG antibody (a,c,e,g).
Fig. 3. Cosedimentation of MxA with nucleocapsids of THOV is
prevented by mAb 2C12. Recombinant MxA was mixed with lysates
of uninfected (A) or THOV-infected cells (B^F) in the presence of
intact IgG molecules or Fab fragments as indicated (C^F). The mix-
tures were subjected to glycerol gradient centrifugation, and the re-
sulting fractions were analyzed by Western blotting using antisera
directed against MxA and viral NP (indicated by arrowheads).
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